VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Zebra 365 who wrote (19684)	3/13/1999 12:32:00 AM
From: BigKNY3	Read Replies (1) of 23519

Zebra <<Off-label uses of drugs are nothing new. >> Dr Z: Thanks for the information in your post. I realize that physicians can legally prescribed medications outside of the approved labeling and in combination therapy. However, pharmaceutical companies are prohibited from promoting or educating physicians for off-label indications. Accordingly, the market for combination ED therapy will always be very limited. However, for some physicians like yourself, this study is encouraging for "the salvage of erectile dysfunction patients desiring noninvasive therapy". BigKNY3 "Is Medicine baseball?"

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next